National HealthCare (NHC) Competitors $129.84 -0.78 (-0.60%) (As of 11/13/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends NHC vs. HIMS, SHC, SGRY, OPCH, GH, PACS, BTSG, LFST, VCYT, and PRVAShould you be buying National HealthCare stock or one of its competitors? The main competitors of National HealthCare include Hims & Hers Health (HIMS), Sotera Health (SHC), Surgery Partners (SGRY), Option Care Health (OPCH), Guardant Health (GH), PACS Group (PACS), BrightSpring Health Services (BTSG), LifeStance Health Group (LFST), Veracyte (VCYT), and Privia Health Group (PRVA). These companies are all part of the "healthcare" industry. National HealthCare vs. Hims & Hers Health Sotera Health Surgery Partners Option Care Health Guardant Health PACS Group BrightSpring Health Services LifeStance Health Group Veracyte Privia Health Group National HealthCare (NYSE:NHC) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, valuation, media sentiment, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership. Is NHC or HIMS more profitable? National HealthCare has a net margin of 10.03% compared to Hims & Hers Health's net margin of 8.19%. Hims & Hers Health's return on equity of 10.97% beat National HealthCare's return on equity.Company Net Margins Return on Equity Return on Assets National HealthCare10.03% 6.87% 4.68% Hims & Hers Health 8.19%10.97%8.29% Which has more risk & volatility, NHC or HIMS? National HealthCare has a beta of 0.41, suggesting that its stock price is 59% less volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.06, suggesting that its stock price is 6% more volatile than the S&P 500. Does the media refer more to NHC or HIMS? In the previous week, Hims & Hers Health had 34 more articles in the media than National HealthCare. MarketBeat recorded 41 mentions for Hims & Hers Health and 7 mentions for National HealthCare. National HealthCare's average media sentiment score of 1.11 beat Hims & Hers Health's score of 0.74 indicating that National HealthCare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment National HealthCare 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 12 Very Positive mention(s) 4 Positive mention(s) 11 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation and earnings, NHC or HIMS? National HealthCare has higher revenue and earnings than Hims & Hers Health. National HealthCare is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNational HealthCare$1.14B1.78$66.80M$7.9816.51Hims & Hers Health$872M6.93-$23.55M$0.4463.98 Does the MarketBeat Community favor NHC or HIMS? Hims & Hers Health received 35 more outperform votes than National HealthCare when rated by MarketBeat users. However, 100.00% of users gave National HealthCare an outperform vote while only 37.11% of users gave Hims & Hers Health an outperform vote. CompanyUnderperformOutperformNational HealthCareOutperform Votes1100.00% Underperform VotesNo VotesHims & Hers HealthOutperform Votes3637.11% Underperform Votes6162.89% Do institutionals & insiders have more ownership in NHC or HIMS? 56.4% of National HealthCare shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 13.8% of National HealthCare shares are held by insiders. Comparatively, 17.7% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts prefer NHC or HIMS? Hims & Hers Health has a consensus price target of $21.21, suggesting a potential downside of 24.64%. Given Hims & Hers Health's stronger consensus rating and higher probable upside, analysts clearly believe Hims & Hers Health is more favorable than National HealthCare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score National HealthCare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Hims & Hers Health 0 Sell rating(s) 8 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.50 SummaryHims & Hers Health beats National HealthCare on 12 of the 18 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Get National HealthCare News Delivered to You Automatically Sign up to receive the latest news and ratings for NHC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NHC vs. The Competition Export to ExcelMetricNational HealthCareSkilled nursing care facilities IndustryMedical SectorNYSE ExchangeMarket Cap$2.03B$3.46B$5.24B$20.06BDividend Yield1.87%1.02%4.99%3.50%P/E Ratio16.5119.1586.3836.88Price / Sales1.781.311,304.9018.70Price / Cash21.2516.3038.9621.64Price / Book2.063.496.484.70Net Income$66.80M$98.56M$118.16M$982.08M7 Day Performance1.08%4.96%-0.07%0.41%1 Month Performance9.43%-8.97%5.61%2.73%1 Year PerformanceN/A23.18%42.32%31.55% National HealthCare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NHCNational HealthCareN/A$129.84-0.6%N/AN/A$2.00B$1.14B16.2713,123Dividend AnnouncementPositive NewsHIMSHims & Hers Health3.6922 of 5 stars$23.41-0.9%N/A+294.3%$5.03B$872M53.211,046Short Interest ↑Gap UpSHCSotera Health3.1757 of 5 stars$16.09+1.6%N/A+17.2%$4.56B$1.05B64.363,000Gap UpSGRYSurgery Partners2.7568 of 5 stars$30.36-0.2%N/A-4.5%$3.86B$2.89B-112.4413,500Analyst ForecastNews CoverageOPCHOption Care Health4.981 of 5 stars$22.48-2.0%N/A-21.9%$3.83B$4.30B18.897,802Insider BuyingShort Interest ↓GHGuardant Health4.6903 of 5 stars$28.61+0.1%N/A+39.7%$3.53B$692.26M-6.751,779Earnings ReportShort Interest ↓PACSPACS Group3.4761 of 5 stars$21.33+7.6%N/AN/A$3.25B$3.11B0.0032,433Gap UpHigh Trading VolumeBTSGBrightSpring Health Services2.9013 of 5 stars$19.57+3.4%N/AN/A$3.20B$8.83B-75.2735,000Short Interest ↓LFSTLifeStance Health Group1.8256 of 5 stars$7.36-4.2%N/A+27.8%$2.82B$1.06B-17.959,325Earnings ReportAnalyst ForecastAnalyst RevisionHigh Trading VolumeVCYTVeracyte4.2038 of 5 stars$36.48-2.3%N/A+72.2%$2.80B$361.05M-243.20790Earnings ReportPRVAPrivia Health Group3.3677 of 5 stars$21.30-5.5%N/A+2.6%$2.55B$1.66B177.511,102 Related Companies and Tools Related Companies HIMS Competitors SHC Competitors SGRY Competitors OPCH Competitors GH Competitors PACS Competitors BTSG Competitors LFST Competitors VCYT Competitors PRVA Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:NHC) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWhat are you hiding Elon?? (Tesla’s secret 69% dividend)Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding National HealthCare Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share National HealthCare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.